Cargando…

Efficacy and safety of oral targeted therapies in pulmonary arterial hypertension: a meta-analysis of randomized clinical trials

Oral targeted therapies play an important role in the treatment of pulmonary arterial hypertension (PAH). Several new oral agents have emerged for PAH in recent years. However, whether they provide a survival advantage is still not clear. This meta-analysis aimed to assess the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Ya-guo, Ma, Hong, Chen, Liang, Jiang, Xiao-min, Zhou, Ling, Lin, Song, Chen, Shao-liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124186/ https://www.ncbi.nlm.nih.gov/pubmed/30124134 http://dx.doi.org/10.1177/2045894018798183

Ejemplares similares

Efficacy and safety of novel-targeted drugs in the treatment of pulmonary arterial hypertension: a Bayesian network meta-analysis
por: Fu, Wenhai, et al.
Publicado: (2021)

Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials
por: Gao, Xiao-Fei, et al.
Publicado: (2017)

Efficacy and safety of macitentan for pulmonary hypertension: A meta‐analysis
por: Du, Dan, et al.
Publicado: (2023)

A Bayesian network meta-analysis on the efficacy and safety of eighteen targeted drugs or drug combinations for pulmonary arterial hypertension
por: Wang, Sumei, et al.
Publicado: (2018)

Efficacy and safety of riociguat in the treatment of chronic thromboembolic pulmonary arterial hypertension: A meta-analysis
por: Ying, Miaofa, et al.
Publicado: (2021)

Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension
por: Chen, Shao-Liang, et al.
Publicado: (2016)

Comparative Efficacy and Safety of Prostacyclin Analogs for Pulmonary Arterial Hypertension: A Network Meta-Analysis
por: Zhang, Huijun, et al.
Publicado: (2016)

Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Effects of oral targeted treatments in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Zhu, Hui-ru, et al.
Publicado: (2022)

Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
por: Beghetti, Maurice, et al.
Publicado: (2017)

Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension
por: Monaco, Thomas J, et al.
Publicado: (2016)

Corrigendum: Efficacy and safety of riociguat replacing PDE-5is for patients with pulmonary arterial hypertension: A systematic review and meta-analysis
por: Liu, Yu-Yang, et al.
Publicado: (2023)

Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis
por: Chen, Yusi, et al.
Publicado: (2021)

Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysis
por: Li, Jie, et al.
Publicado: (2022)

Meta-analysis of randomized controlled trials of bosentan for treatment of pulmonary arterial hypertension
por: Lee, Young Ho, et al.
Publicado: (2013)

CD248 as a novel therapeutic target in pulmonary arterial hypertension
por: Xu, Tao, et al.
Publicado: (2020)

The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
por: Shu, Tingting, et al.
Publicado: (2021)

The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients
por: Zhao, Cong, et al.
Publicado: (2022)

Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2015)

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
por: Kuwana, Masataka, et al.
Publicado: (2023)

Hemodynamic, Functional, and Clinical Responses to Pulmonary Artery Denervation in Patients With Pulmonary Arterial Hypertension of Different Causes: Phase II Results From the Pulmonary Artery Denervation-1 Study
por: Chen, Shao-Liang, et al.
Publicado: (2015)

Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension
por: Dong, Li, et al.
Publicado: (2014)

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
por: Galiè, Nazzareno, et al.
Publicado: (2009)

A Study of the Efficacy and Safety of Aerobic Exercise Training in Pulmonary Arterial Hypertension (the Saturday Study): Protocol for a Prospective, Randomized, and Controlled Trial
por: Jiang, Rong, et al.
Publicado: (2022)

Sotatercept for the treatment of pulmonary arterial hypertension: a meta-analysis of randomized controlled trials
por: Jaiswal, Vikash, et al.
Publicado: (2023)

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2020)

Efficacy and Safety of Bronchial Artery Embolization on Hemoptysis in Chronic Thromboembolic Pulmonary Hypertension: A Pilot Prospective Cohort Study
por: Yang, Suqiao, et al.
Publicado: (2019)

Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
por: Chen, Yuqin, et al.
Publicado: (2019)

Efficacy and safety of oral zinc sulfate in the prevention of chemotherapy-induced oral mucositis: Protocol for a meta-analysis of randomized controlled trials
por: Tian, Xu, et al.
Publicado: (2018)

Pulmonary artery denervation improves hemodynamics and cardiac function in pulmonary hypertension secondary to heart failure
por: Zhang, Hang, et al.
Publicado: (2018)

Efficacy of stem cell therapy for pulmonary arterial hypertension: a systematic review and meta-analysis of preclinical studies
por: Ding, Xian-Fei, et al.
Publicado: (2019)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: A systematic review and meta-analysis
por: Zhang, Ruihua, et al.
Publicado: (2022)

Pulmonary mucormycosis: a case of pulmonary arterial hypertension, Westermark sign, and bronchopleural fistula
por: Shao, Weipeng, et al.
Publicado: (2020)

The limits of oral therapy in pulmonary arterial hypertension management
por: Liu, Qian-Qian, et al.
Publicado: (2015)

Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension
por: Khan, Akram, et al.
Publicado: (2022)

Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
por: Roberts, Kari E, et al.
Publicado: (2009)

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Rysz-Górzynska, Magdalena, et al.
Publicado: (2016)

Correction to: Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study
por: Chen, Yuqin, et al.
Publicado: (2020)

Efficacy and Safety of Novel Oral Antivirals in Hospitalized COVID-19 Patients: A Network Meta-Analysis of Randomized Clinical Trials
por: Liu, Haoshuang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_df4745pncn797c0iqoa4m86uf3